| Ytd | 73.37% | |
| 1y | 60.57% |
| Open | 19.90 | Prev Close | 20.14 | Low | 19.90 | High | 20.58 | Mkt Cap | 3.08B |
| Vol | 118.35K | Avg Vol | 2.72M | EPS | -2.73 | P/E | N/A | Forward P/E | 8.93 |
| Beta | 1.39 | Short Ratio | 4.48 | Inst. Own | 88.52% | Dividend | 0.35 | Div Yield | 1.71 |
| Ex Div Date | 05-15 | Earning | 08-04 | 50-d Avg | 22.94 | 200-d Avg | 17.61 | 1yr Est | 25.44 |
Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and lowers the price t
Stockholm, July 1st, 2026 – Virtune today announces the completion of the rebalancing for the Virtun
Chemours (CC) was a big mover last session on higher-than-average trading volume. The latest trend i
Chemours Reaches Agreement with U.S. EPA to Resolve Claims Relating to PFAS PR Newswire WILMINGTON,
The settlement resolves the federal government's claims relating to discharge of PFAS compounds acro
NEW YORK, June 18, 2026 /PRNewswire/ -- Canton Strategic Holdings, Inc. (NASDAQ: CNTN) ("Canton Stra
Chemours (CC) reported earnings 30 days ago. What's next for the stock?
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and raises the pr
American manufacturing is having a moment. Reshoring incentives, the AIM Act refrigerant transition,
/PRNewswire/ -- A new industry study released today and developed by a technical working group co-le
ONON is experiencing a dip in trading today, despite a robust Q1 earnings report released this morni
Morgan Stanley analyst Vincent Andrews maintains Chemours (NYSE:CC) with a Equal-Weight and raise
Analysts changed outlook on top names, RBC raised CC price target, DA Davidson lowered MSA target, O
Wall Street has rarely been louder with bubble warnings on the AI trade after the parabolic moves we
Wall Street has rarely been louder with bubble warnings on the AI trade after the parabolic moves we
RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:CC) with a Outperform and raises th
Chemours NYSE: CC said it opened 2026 with first-quarter results that were “well above earnings expe
CC posted a wider Q1 loss as lower volumes hurt key segments, but pricing gains and upbeat Q2 sales
The Chemours Company (CC) Q1 2026 Earnings Call Transcript
Memory is yesterday's trade. Liquid cooling is the next AI backlog story — Carrier orders up 500
WILMINGTON, Del., May 5, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today ann
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter en
This specialty chemicals provider supplies titanium technologies and advanced materials to a broad r
Full Year 2026 Outlook The Company continues to expect 2026 Net Sales to grow in the range of 3% to
Second Quarter 2026 Outlook In the second quarter, the Company anticipates consolidated Net Sales to
WILMINGTON, Del., May 5, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NY
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and raises the
VICTORIA, Seychelles, April 24, 2026 (GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Excha
On April 23, 2026, Hasbro Inc (HAS) released its 8-K filing detailing preliminary first-quarter 2026
WILMINGTON, Del., April 21, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company")
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and raises the
Dow Jones up 150 pts, Citi Trends $CTRN up 20.8% on strong earnings, other big gainers include Getty
BMO warns Middle East conflict is the biggest oil market event in decades. See how supply risks are
Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and raises the price t
Goldman Sachs analyst Duffy Fischer maintains Chemours (NYSE:CC) with a Neutral and raises the pr
Successful qualification of Opteon™ fluid in 2CRSi server sparks broader collaboration to drive inno
BMO Capital analyst John McNulty maintains Chemours (NYSE:CC) with a Outperform and lowers the pr
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and raises the pr
Morgan Stanley analyst Vincent Andrews maintains Chemours (NYSE:CC) with a Equal-Weight and raise
Chemours (NYSE:CC) reported quarterly earnings of $0.05 per share which missed the analyst consensus
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and raises the
The Chemours Company ("Chemours" or "the Company") (NYSE:CC), a global chemistry com
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the pr
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the